The HCPLive pain page is a resource for medical news and expert insights on pain medicine. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for acute pain, chronic pain, addiction medicine, and more.
April 29th 2024
FDA issued a CRL the abbreviated new drug application of ketamine, which had sought to enhance accessibility to the limited drug supply.
Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
How Can I Help?: Streamlining Call Management
The impetus for Alfred I. DuPont Hospital for Children’s switch to a centralized system came about because the hospital administrators wanted patients communicating with live people. An admirable goal for sure, but with only two live people available to take calls at anyone time, patients often ended up spending 15 minutes on hold waiting for a human voice, becoming frustrated and hanging up.
Glucosamine May Not Aid Osteoarthritic Knees
October 17th 2009Prior studies of glucosamine and its role in the prevention of joint damage in knee OA have produced conflicting results, but a recent study found that the odds of worsening cartilage damage in a glucosamine group were the same as for patients given a placebo.
Anti-TNF Therapy for Rheumatoid Arthritis May Increase Risk of Joint Infections
October 17th 2009Anti tumor necrosis factor therapy for rheumatoid arthritis appears to increase a patient's risk of developing septic arthritis, which is the infection of a joint, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Philadelphia, PA.
Adverse Reactions to Infusion Therapy
In a session that focused on potential adverse reactions to rheumatologic infusion therapies, Jacqueline M. Fritz, RN, MSN, CNS, Arthritis and Osteoporosis, La Palma, California, explained that infusion therapies take time to administer.
Rooting Out Fraud Part 3: Billing Abuse by an Anesthesia Group
I was out of town on business and had a 'slip & fall.' After many tries and many hours on the phone, Oxford could not direct us to a plan orthopedist—hand surgeon? Yes; Foot and ankle? Didn't happen. Ironically (or was it?), that bureaucratic hurdle saved them a bundle.
Alcohol Use Common Among Chronic Pain Patients
October 6th 2009Professionals should educate and monitor their pain patients' use of alcohol according to a University of Florida study which found that use of alcohol as a pain management strategy was consistent across the three patient groups, ranging from 25 to 28 percent. Use was more prevalent in men and corresponded to higher income levels.
Signaling Molecules May Limit Bone Destruction and Bone Loss from RA
September 29th 2009Researchers have discovered a new way to use the role of signaling molecules to inhibit another complex that plays a key role in the ‘turning on’ of genes “that cause the stem cell precursors of osteoclasts to mature and start eating bone,” a discovery that may lead to the formation of new rheumatoid arthritis and osteoporosis drugs.
Migraine Sufferers Better Off Staying Home than Working through the Pain
September 29th 2009Individuals who go to work with a migraine, with the thought that it is better to “endure the pain” and stay at work, are actually less productive than individuals who stay home because of a migraine, with the level of productivity while suffering from a migraine is impacted by whether the migraine is chronic or episodic, the results of two new studies show.
Excessive Bone Growth Following Trauma, Surgery Can be Stopped
September 28th 2009Using an experimental drug, Thomas Jefferson University researchers were able to prevent heterotopic ossification in animal models, giving hope that human treatments will follow for this disease affecting up to 70 percent of severely-wounded soldiers.
Stress in the Workplace may Decrease an Individual's Risk for Developing Rheumatoid Arthritis
September 10th 2009Psychosocial work stress has been previously associated with an increased risk for cardiovascular disease. New research now reveals that high work stress may actually decrease an individual's chance of developing inflammatory conditions, including rheumatoid arthritis.